S1PR1 and myeloid sarcoma: Their main mechanism of action in MS is blocking the S1P-dependent egress of lymphocytes from lymph nodes into the bloodstream by binding and internalizing the S1PR1 on lymphocytes, thus limiting lymphocyte infiltration in the CNS.